We are live on ! Find out more
CRVO icon

CervoMed
CRVO

17 hedge funds and large institutions have $1.04M invested in CervoMed in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

0.01% less ownership

Funds ownership: 0.14% → 0.13% (-0.01%)

6% less funds holding

Funds holding: 18 → 17 (-1)

35% less capital invested

Capital invested by funds: $1.59M → $1.04M (-$550K)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$372K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$52.7K
3
Millennium Management
Millennium Management
New York
+$24.3K
4
Bank of America
Bank of America
North Carolina
+$8.95K
5
UBS Group
UBS Group
Switzerland
+$8.19K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$500K
2
Barclays
Barclays
United Kingdom
-$61.9K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$31.1K
4
Creative Planning
Creative Planning
Kansas
-$9K
5
FAN
Financial Advisors Network
California
-$5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$532K +$372K +12,278 +121%
BlackRock
2
BlackRock
New York
$260K – – –
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$119K +$52.7K +1,738 +52%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$55K -$31.1K -1,026 -31%
UBS Group
5
UBS Group
Switzerland
$20K +$8.19K +270 +48%
Millennium Management
6
Millennium Management
New York
$19K +$24.3K +800 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$9K – – –
Bank of America
8
Bank of America
North Carolina
$9K +$8.95K +295 +410%
SRCM
9
Swift Run Capital Management
Virginia
$5K – – –
PAG
10
Private Advisor Group
New Jersey
$4K +$789 +26 +18%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$4K +$4.67K +154 New
Two Sigma Advisers
12
Two Sigma Advisers
New York
$4K +$5.22K +172 New
SWM
13
Sugarloaf Wealth Management
Georgia
$1K +$182 +6 +13%
SM
14
Sabby Management
Florida
– -$500K -14,473 Closed
Barclays
15
Barclays
United Kingdom
– -$61.9K -2,041 -100%
Creative Planning
16
Creative Planning
Kansas
– -$9K -269 Closed
FAN
17
Financial Advisors Network
California
– -$5K -133 Closed
Wells Fargo
18
Wells Fargo
California
– -$2K -66 -99%
Osaic Holdings
19
Osaic Holdings
Arizona
– +$728 +24 New

CRVO Hedge Fund Activity: Q1 2020 in Review

17 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q1 2020, worth a combined $1.04M — down 35% from $1.59M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CRVO positions and 3 closed out — a net gain of 1 holder — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $372K. The largest seller was Sabby Management, exiting entirely with an estimated $500K sold.

  • 17 institutional investors held CervoMed (CRVO) as of Q1 2020, down from 18 in Q4 2019.
  • Funds reported $1.04M of CervoMed stock for Q1 2020, down 35% quarter-over-quarter.
  • 4 funds opened new CervoMed positions in Q1 2020 and 3 closed out, a net change of +1 holder.
  • The largest CervoMed buyer in Q1 2020 was Renaissance Technologies, an estimated $372K added.
  • The largest CervoMed seller in Q1 2020 was Sabby Management, an estimated $500K sold.

Based on aggregated 13F filings for Q1 2020.